Patents by Inventor Maria Wilhelmina Elisabeth MONS

Maria Wilhelmina Elisabeth MONS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cathepsin inhibitors
    Patent number: 11820734
    Abstract: This invention relates to compounds that are useful as inhibitors, in particular as inhibitors of Cathepsin K (CatK), and to a method of inhibiting cathepsin activity, comprising administering a compound or formulation comprising a compound according to the invention.
    Type: Grant
    Filed: October 20, 2021
    Date of Patent: November 21, 2023
    Assignee: ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC)
    Inventors: Huib Ovaa, Maria Wilhelmina Elisabeth Mons, Stan Van Boeckel
  • CATHEPSIN INHIBITORS
    Publication number: 20220227705
    Abstract: This invention relates to compounds that are useful as inhibitors, in particular as inhibitors of Cathepsin K (CatK), and to a method of inhibiting cathepsin activity, comprising administering a compound or formulation comprising a compound according to the invention.
    Type: Application
    Filed: October 20, 2021
    Publication date: July 21, 2022
    Applicant: ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC)
    Inventors: Huib OVAA, Maria Wilhelmina Elisabeth MONS, Stan VAN BOECKEL
  • Cathepsin inhibitors
    Patent number: 11174224
    Abstract: This invention relates to compounds that are useful as inhibitors, in particular as inhibitors of Cathepsin K (CatK), and to a method of inhibiting cathepsin activity, comprising administering a compound or formulation comprising a compound according to the invention.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: November 16, 2021
    Assignee: ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC)
    Inventors: Huib Ovaa, Maria Wilhelmina Elisabeth Mons, Stan Van Boeckel
  • CATHEPSIN INHIBITORS
    Publication number: 20200385341
    Abstract: This invention relates to compounds that are useful as inhibitors, in particular as inhibitors of Cathepsin K (CatK), and to a method of inhibiting cathepsin activity, comprising administering a compound or formulation comprising a compound according to the invention.
    Type: Application
    Filed: December 5, 2018
    Publication date: December 10, 2020
    Applicant: ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC)
    Inventors: Huib OVAA, Maria Wilhelmina Elisabeth MONS, Stan VAN BOECKEL